Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page
- Check7 days agoChange DetectedThe page now includes related topics: Prostate cancer and MedlinePlus Genetics. These additions provide quick access to background information and genetics resources relevant to the study.SummaryDifference0.2%

- Check14 days agoChange DetectedThe related topics area was trimmed by removing the 'Prostate cancer' label and the 'MedlinePlus Genetics' item, reducing navigational references without changing the study information.SummaryDifference0.2%

- Check21 days agoChange DetectedMinor release update to the page template/footer (version bump) and adds a related topic entry for “Prostate cancer” linking to MedlinePlus Genetics. No study-specific information (e.g., treatments, eligibility, outcomes, or results) appears altered.SummaryDifference0.2%

- Check29 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check43 days agoChange DetectedThe Related Topics section no longer lists Prostate Cancer and MedlinePlus Genetics, removing direct links to these topics from the page.SummaryDifference0.2%

- Check57 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.